Literature DB >> 26401700

APOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease: Age Matters.

Xiaoying Tang1, Dominic Holland2, Anders M Dale2,3, Michael I Miller1,4,5.   

Abstract

This paper examines how age intervenes in the effects of APOE ɛ4 allele on the volume and shape morphometrics of the hippocampus and the amygdala in mild cognitive impairment (MCI) and Alzheimer's disease. We evaluate the structural morphological differences between ɛ4 carriers and non-carriers in two age-dependent subgroups; younger than 75 years (Young-Old) and older than 80 years (Very-Old). While we show that the four structures of interest atrophy significantly in the ɛ4 carriers, relative to the non-carriers, of the Young-Old group, this effect is not observed in their Very-Old counterparts. The structures in the right hemisphere are found to be more affected by the APOE genotype than those in the left hemisphere and we identify the relevant regions in which significant atrophy occurs to be parts of the basolateral, centromedial, and lateral nucleus subregions of the amygdala and the CA1 and subiculum subregions of the hippocampus. We also observe that the APOE genotype only affects MCI patients that deteriorated to dementia within 3 years while leaving their "non-converting" counterparts unaffected.

Entities:  

Keywords:  Age intervention; Alzheimer’s disease; amygdala; apolipoprotein E; conversion; hippocampus; mild cognitive impairment; shape morphometrics

Mesh:

Substances:

Year:  2015        PMID: 26401700      PMCID: PMC5479937          DOI: 10.3233/JAD-150262

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  61 in total

1.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

2.  Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors.

Authors:  Emily C Edmonds; Lisa Delano-Wood; Lindsay R Clark; Amy J Jak; Daniel A Nation; Carrie R McDonald; David J Libon; Rhoda Au; Douglas Galasko; David P Salmon; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2014-05-22       Impact factor: 21.566

3.  Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.

Authors:  David A Wolk; Bradford C Dickerson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

4.  The diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease.

Authors:  Xiaoying Tang; Dominic Holland; Anders M Dale; Laurent Younes; Michael I Miller
Journal:  Hum Brain Mapp       Date:  2015-02-03       Impact factor: 5.038

5.  Apolipoprotein E and cognitive performance: a meta-analysis.

Authors:  Brent J Small; Christopher B Rosnick; Laura Fratiglioni; Lars Bäckman
Journal:  Psychol Aging       Date:  2004-12

6.  Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.

Authors:  Johanna Lind; Anne Larsson; Jonas Persson; Martin Ingvar; Lars-Göran Nilsson; Lars Bäckman; Rolf Adolfsson; Marc Cruts; Kristel Sleegers; Christine Van Broeckhoven; Lars Nyberg
Journal:  Neurosci Lett       Date:  2006-01-06       Impact factor: 3.046

7.  The limbic system in Alzheimer's disease. A neuropathologic investigation.

Authors:  M W Hopper; F S Vogel
Journal:  Am J Pathol       Date:  1976-10       Impact factor: 4.307

8.  Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia.

Authors:  Federica Agosta; Keith A Vossel; Bruce L Miller; Raffaella Migliaccio; Stephen J Bonasera; Massimo Filippi; Adam L Boxer; Anna Karydas; Katherine L Possin; Maria Luisa Gorno-Tempini
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-22       Impact factor: 11.205

9.  MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.

Authors:  L Mosconi; D Perani; S Sorbi; K Herholz; B Nacmias; V Holthoff; E Salmon; J-C Baron; M T R De Cristofaro; A Padovani; B Borroni; M Franceschi; L Bracco; A Pupi
Journal:  Neurology       Date:  2004-12-28       Impact factor: 9.910

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  14 in total

1.  Surface-based vertexwise analysis of morphometry and microstructural integrity for white matter tracts in diffusion tensor imaging: With application to the corpus callosum in Alzheimer's disease.

Authors:  Xiaoying Tang; Yuanyuan Qin; Wenzhen Zhu; Michael I Miller
Journal:  Hum Brain Mapp       Date:  2017-01-13       Impact factor: 5.038

2.  Hippocampal synaptic and neural network deficits in young mice carrying the human APOE4 gene.

Authors:  Guo-Zhu Sun; Yong-Chang He; Xiao Kuang Ma; Shuang-Tao Li; De-Jie Chen; Ming Gao; Shen-Feng Qiu; Jun-Xiang Yin; Jiong Shi; Jie Wu
Journal:  CNS Neurosci Ther       Date:  2017-08-07       Impact factor: 5.243

3.  APOE modifies the interaction of entorhinal cerebral blood flow and cortical thickness on memory function in cognitively normal older adults.

Authors:  Chelsea C Hays; Zvinka Z Zlatar; M J Meloy; Mark W Bondi; Paul E Gilbert; Thomas T Liu; Jonathan L Helm; Christina E Wierenga
Journal:  Neuroimage       Date:  2019-09-04       Impact factor: 6.556

4.  Shape and diffusion tensor imaging based integrative analysis of the hippocampus and the amygdala in Alzheimer's disease.

Authors:  Xiaoying Tang; Yuanyuan Qin; Jiong Wu; Min Zhang; Wenzhen Zhu; Michael I Miller
Journal:  Magn Reson Imaging       Date:  2016-05-20       Impact factor: 2.546

5.  Radiomic Features of Hippocampal Subregions in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.

Authors:  Feng Feng; Pan Wang; Kun Zhao; Bo Zhou; Hongxiang Yao; Qingqing Meng; Lei Wang; Zengqiang Zhang; Yanhui Ding; Luning Wang; Ningyu An; Xi Zhang; Yong Liu
Journal:  Front Aging Neurosci       Date:  2018-09-25       Impact factor: 5.750

6.  Apolipoprotein E ε4 Specifically Modulates the Hippocampus Functional Connectivity Network in Patients With Amnestic Mild Cognitive Impairment.

Authors:  Lin Zhu; Hao Shu; Duan Liu; Qihao Guo; Zan Wang; Zhijun Zhang
Journal:  Front Aging Neurosci       Date:  2018-09-27       Impact factor: 5.750

7.  The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study.

Authors:  Manish D Paranjpe; Xueqi Chen; Min Liu; Ishan Paranjpe; Jeffrey P Leal; Rongfu Wang; Martin G Pomper; Dean F Wong; Tammie L S Benzinger; Yun Zhou
Journal:  Neuroimage Clin       Date:  2019-03-28       Impact factor: 4.881

8.  Association Between Hippocampus, Thalamus, and Caudate in Mild Cognitive Impairment APOEε4 Carriers: A Structural Covariance MRI Study.

Authors:  Fabiana Novellino; María Eugenia López; Maria Grazia Vaccaro; Yus Miguel; María Luisa Delgado; Fernando Maestu
Journal:  Front Neurol       Date:  2019-12-20       Impact factor: 4.003

9.  A profile of brain reserve in adults at genetic risk of Alzheimer's disease.

Authors:  Gillian Coughlan; Peter Zhukovsky; Aristotle Voineskos; Cheryl Grady
Journal:  Alzheimers Dement (Amst)       Date:  2021-06-09

10.  Multiparametric imaging hippocampal neurodegeneration and functional connectivity with simultaneous PET/MRI in Alzheimer's disease.

Authors:  Shaozhen Yan; Chaojie Zheng; Bixiao Cui; Zhigang Qi; Zhilian Zhao; Yanhong An; Liyan Qiao; Ying Han; Yun Zhou; Jie Lu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-03-10       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.